OBJECTIVE: Tuberculosis is still one of the most severe chronic diseases, especially in the world's poorest regions. Developing countries still have to face serious problems related to this endemic disease, in spite of the control programs they have implemented. The present study aims at updating the diagnosis and treatment of tuberculosis in three South American countries: Brazil, Chile and Argentina. SOURCES: Medline and Lilacs databases, official guidelines and consensuses of the three countries involved. SUMMARY OF THE FINDINGS: Brazil, Chile and Argentina have guidelines based on the World Health Organization documents and on international consensuses. The standardization is similar between these countries, allowing the unification of language and favoring control measures. Within the Brazilian context, the new guidelines on the treatment of tuberculosis set out by the Ministry of Health are presented. CONCLUSIONS: Since each country had to make adaptations in an attempt to solve the epidemiological differences between them, the treatments against tuberculosis still present some discrepancies, such as the use of three or four drugs in some cases.
OBJECTIVE:Tuberculosis is still one of the most severe chronic diseases, especially in the world's poorest regions. Developing countries still have to face serious problems related to this endemic disease, in spite of the control programs they have implemented. The present study aims at updating the diagnosis and treatment of tuberculosis in three South American countries: Brazil, Chile and Argentina. SOURCES: Medline and Lilacs databases, official guidelines and consensuses of the three countries involved. SUMMARY OF THE FINDINGS: Brazil, Chile and Argentina have guidelines based on the World Health Organization documents and on international consensuses. The standardization is similar between these countries, allowing the unification of language and favoring control measures. Within the Brazilian context, the new guidelines on the treatment of tuberculosis set out by the Ministry of Health are presented. CONCLUSIONS: Since each country had to make adaptations in an attempt to solve the epidemiological differences between them, the treatments against tuberculosis still present some discrepancies, such as the use of three or four drugs in some cases.
Authors: Angelica E Miranda; Reynaldo Dietze; Ethel L Maciel; Thiago N Prado; Antonio L Caus; Murilo M Silva; Jonathan E Golub Journal: J Trop Pediatr Date: 2010-09-28 Impact factor: 1.165
Authors: Roberta Feijó Carvalho; Anna Cristina Calçada Carvalho; Luis Guillermo Coca Velarde; Andrea Maciel de Oliveira Rossoni; Rafaela Baroni Aurilio; Selma Maria de Azevedo Sias; Christiane Mello Schmidt; Adriana da Silva Rezende Moreira; Pedro da Silva Martins; Lorrayne Isidoro Gonçalves; Terezinha Miceli Martire; Ana Paula Ferreira Barbosa; Ana Paula Quintanilha Dos Santos; Roberta Maia de Castro Romanelli; Maria das Graças Rodrigues de Oliveira; Lilian Martins Oliveira Diniz; Andrea Lucchesi de Carvalho; Sheila Cunha Lucena; Maria Letícia Santos Cruz; Mariza Curto Saavedra; Tony Tannous Tahan; Cristina de Oliveira Rodrigues; Afrânio Lineu Kritski; Clemax Couto Sant'Anna; Claudete Aparecida Araújo Cardoso; Maria de Fátima Bazhuni Pombo Sant'Anna Journal: Rev Inst Med Trop Sao Paulo Date: 2020-10-30 Impact factor: 1.846